SG11201508388YA - Methods for enhancing aged muscle regeneration - Google Patents

Methods for enhancing aged muscle regeneration

Info

Publication number
SG11201508388YA
SG11201508388YA SG11201508388YA SG11201508388YA SG11201508388YA SG 11201508388Y A SG11201508388Y A SG 11201508388YA SG 11201508388Y A SG11201508388Y A SG 11201508388YA SG 11201508388Y A SG11201508388Y A SG 11201508388YA SG 11201508388Y A SG11201508388Y A SG 11201508388YA
Authority
SG
Singapore
Prior art keywords
enhancing
methods
muscle regeneration
aged muscle
aged
Prior art date
Application number
SG11201508388YA
Other languages
English (en)
Inventor
Sean Garvey
Suzette Pereira
Neile Edens
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SG11201508388YA publication Critical patent/SG11201508388YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201508388YA 2013-05-01 2014-05-01 Methods for enhancing aged muscle regeneration SG11201508388YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361818237P 2013-05-01 2013-05-01
PCT/US2014/036297 WO2014179526A1 (en) 2013-05-01 2014-05-01 Methods for enhancing aged muscle regeneration

Publications (1)

Publication Number Publication Date
SG11201508388YA true SG11201508388YA (en) 2015-11-27

Family

ID=50885012

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201508388YA SG11201508388YA (en) 2013-05-01 2014-05-01 Methods for enhancing aged muscle regeneration

Country Status (11)

Country Link
US (1) US20160066610A1 (enExample)
EP (1) EP2999359A1 (enExample)
JP (1) JP2016520050A (enExample)
CN (1) CN105188413A (enExample)
BR (1) BR112015027563A2 (enExample)
CA (1) CA2911471A1 (enExample)
HK (1) HK1221609A1 (enExample)
MX (1) MX2015015178A (enExample)
PH (1) PH12015502319A1 (enExample)
SG (1) SG11201508388YA (enExample)
WO (1) WO2014179526A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015094772A1 (en) * 2013-12-18 2015-06-25 Abbott Laboratories Methods for increasing skeletal muscle protein synthesis using green tea extract
WO2016044272A1 (en) * 2014-09-16 2016-03-24 Abbott Laboratories Methods of preserving muscle strength during a period of muscle disuse by administering beta-hydroxy-beta-methylbutyrate and green tea extract
JP6664956B2 (ja) * 2015-02-27 2020-03-13 キリンホールディングス株式会社 筋分化促進組成物
US10596138B2 (en) 2015-09-16 2020-03-24 Abbott Laboratories Reduced fat, shelf stable liquid nutritional composition
WO2017123922A1 (en) * 2016-01-13 2017-07-20 Metabolic Technologies, Inc. COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) FOR JOINT STABILITY
ES2811378T3 (es) * 2016-04-01 2021-03-11 Dsm Ip Assets Bv Bebidas que comprenden gránulos estables de luteína molida
MX2018014407A (es) 2016-05-25 2019-02-21 Tsi Group Ltd Estabilizacion de formulaciones de acido beta-hidroxiisovalerico en capsulas de gel blando.
US20210368843A1 (en) * 2016-08-04 2021-12-02 Seattle Gummy Company Mineral compositions and methods of making and using thereof
CN109661180A (zh) * 2016-08-04 2019-04-19 西雅图咖米公司 用于运动成绩的组合物及其制造和使用方法
WO2018027081A1 (en) * 2016-08-04 2018-02-08 Seattle Gummy Company Health management compositions and methods of making and using thereof
EP3528801B1 (en) 2016-10-21 2024-07-17 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (hmb) and probiotics
US12370159B2 (en) 2016-10-21 2025-07-29 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics
BR112019023794A2 (pt) 2017-06-09 2020-06-02 Philip Morris Products S.A. Artigo gerador de aerossol com segmento de filtro fibroso
US20190037904A1 (en) * 2017-08-04 2019-02-07 Sean R. Daly Food-based protein formulation
MX392627B (es) * 2018-02-09 2025-03-24 Haldor Topsoe As Proceso de produccion de compuestos de alfa-hidroxi y usos de los mismos
CN112312772A (zh) * 2018-06-23 2021-02-02 西雅图咖米公司 用于降低咖啡因副作用的方法和组合物
JP6541047B1 (ja) * 2018-10-18 2019-07-10 株式会社東洋新薬 経口組成物
CA3175049A1 (en) * 2020-03-10 2021-04-15 The Regents Of The University Of California Novel nutrients to enhance load-induced muscle hypertrophy
WO2021236440A1 (en) 2020-05-20 2021-11-25 Advanced Food Concepts, Inc. Athletic performance enhancement composition using menthol
CN112568444A (zh) * 2020-11-20 2021-03-30 格乐瑞(无锡)营养科技有限公司 一种缓解肌肉流失的组合物及其制备方法
WO2023190293A1 (ja) * 2022-03-30 2023-10-05 ニュートリー株式会社 とろみ状栄養組成物
WO2025030001A2 (en) * 2023-08-02 2025-02-06 Abbott Laboratories Methods and compositions for maintaining skeletal muscle mobility and/or mass, and/or for recovery of skeletal muscle strength

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
ATE508745T1 (de) * 2005-11-30 2011-05-15 Novartis Pharma Gmbh Kombination umfassend mindestens eine aminosäure und einen pkr-inhibitor zur verwendung in der behandlung von muskelschwund
WO2007116962A1 (ja) * 2006-04-07 2007-10-18 Osaka University 筋再生促進剤
JP5507802B2 (ja) * 2006-08-10 2014-05-28 花王株式会社 筋肉老化抑制剤
EP3231435A1 (en) * 2009-07-20 2017-10-18 Nestec S.A. Methods of attenuating the loss of functional status
CA2821312A1 (en) * 2010-12-27 2012-07-05 Abbott Laboratories Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
WO2012097061A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
WO2012097064A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose

Also Published As

Publication number Publication date
EP2999359A1 (en) 2016-03-30
MX2015015178A (es) 2016-02-26
CN105188413A (zh) 2015-12-23
PH12015502319A1 (en) 2016-02-10
CA2911471A1 (en) 2014-11-06
JP2016520050A (ja) 2016-07-11
HK1221609A1 (zh) 2017-06-09
US20160066610A1 (en) 2016-03-10
BR112015027563A2 (pt) 2017-07-25
WO2014179526A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
SG11201508388YA (en) Methods for enhancing aged muscle regeneration
GB201314695D0 (en) Method
GB201318465D0 (en) Method
GB201320351D0 (en) Method
GB201309057D0 (en) Method
PL2969393T3 (pl) Sposób reprofilowania szyny
IL240753A0 (en) Antibody purification methods
GB201316849D0 (en) Method
ZA201600018B (en) Method for improving adherence
GB201309928D0 (en) Method
GB201301857D0 (en) Method
GB201313249D0 (en) Method
GB201300409D0 (en) Method
TWI563128B (en) Methods for treating aluminum surfaces
GB201309654D0 (en) Method
GB201305714D0 (en) Method
GB201311385D0 (en) Method
GB201301094D0 (en) Method
SG11201601264UA (en) Soil-volume reduction method
GB201318490D0 (en) Method
GB201314054D0 (en) Method
GB201311389D0 (en) Method
GB201320660D0 (en) Method
GB201319361D0 (en) Method
GB201318830D0 (en) Method